{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:33:15Z","timestamp":1793665995533,"version":"4.5.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011151","name":"American Academy of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011238","name":"Lions Clubs International Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ajo.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T17:18:48Z","timestamp":1615828728000},"page":"100-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy"],"prefix":"10.1016","volume":"227","author":[{"given":"Marianne O.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Francis W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajo.2021.03.006_bib0001","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/jamaophthalmol.2018.2031","article-title":"Association of the gutta-induced microenvironment with corneal endothelial cell behavior and demise in Fuchs endothelial corneal dystrophy","volume":"136","author":"Kocaba","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.006_bib0002","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jcrs.2014.09.042","article-title":"Refractive outcomes of Descemet membrane endothelial keratoplasty triple procedures (combined with cataract surgery)","volume":"41","author":"Schoenberg","year":"2015","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.006_bib0003","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/ICO.0000000000002227","article-title":"Implantation of presbyopia-correcting intraocular lenses staged after Descemet membrane endothelial keratoplasty in patients with Fuchs dystrophy","volume":"39","author":"Price","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2021.03.006_bib0004","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2021.03.006_bib0005","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa1712770","article-title":"Injection of cultured cells with a ROCK inhibitor for bullous keratopathy","volume":"378","author":"Kinoshita","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajo.2021.03.006_bib0006","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.ophtha.2018.06.018","article-title":"Patient-reported visual disability in Fuchs\u2019 endothelial corneal dystrophy measured by the Visual Function and Corneal Health Status instrument","volume":"125","author":"Wacker","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2021.03.006_bib0007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exer.2011.09.009","article-title":"Cell signaling in regulation of the barrier integrity of the corneal endothelium","volume":"95","author":"Srinivas","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2021.03.006_bib0008","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vph.2015.03.017","article-title":"ROCK2 primes the endothelium for vascular hyperpermeability responses by raising baseline junctional tension","volume":"70","author":"Beckers","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.ajo.2021.03.006_bib0009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajo.2020.09.050","article-title":"Randomized, double-masked trial of netarsudil 0.02% ophthalmic solution for prevention of corticosteroid-induced ocular hypertension","volume":"222","author":"Price","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.006_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2020.04.002","article-title":"Reticular bullous epithelial edema in corneas treated with netarsudil: a case series","volume":"217","author":"Wisely","year":"2020","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:43:56Z","timestamp":1762080236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":10,"alternative-id":["S0002939421001197"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.006","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}